Stopping Nifty weekly expiry will deprive hedging opportunity: Anand James

Stopping Nifty weekly expiry will deprive hedging opportunity: Anand James

After BSE has announced that it will discontinue Bankex weekly expiries, the market is rife with speculations that NSE may choose Nifty Bank over Nifty as both exchanges have to pick one expiry under new Sebi rules. Nifty Bank brings in higher volumes for the exchange, and better trading opportunities for speculators, but if Nifty … Read more

Stocks in news: General Insurance Corp, ONGC, SpiceJet, GSK Pharma, Cipla

Stocks in news: General Insurance Corp, ONGC, SpiceJet, GSK Pharma, Cipla

Domestic markets traded subdued and ended the day nearly unchanged, continuing the ongoing gradual uptrend. In today’s trade, shares of General Insurance Corp, ONGC, SpiceJet, GSK Pharma, Cipla among others will be in focus due to various news developments. General Insurance CorpThe government has proposed to sell 6.78% stake in General Insurance Corporation of India … Read more

We would keep 12-15% cash and wait for stocks that would outperform over next 12 months: Sandip Sabharwal

We would keep 12-15% cash and wait for stocks that would outperform over next 12 months: Sandip Sabharwal

Sandip Sabharwal, asksandipsabharwal.com, says “the markets have corrected and people are correlating it to what might happen in the election. I do not think that is the right way to do it. I think markets fall under their own weight when they become overweight. So, the Indian market became overweight and is correcting a bit. … Read more

NSE to introduce 4 new indices in capital, F&O segments from April 8

NSE to introduce 4 new indices in capital, F&O segments from April 8

MUMBAI – The National Stock Exchange (NSE) of India will launch four new indices in the cash and futures and options segments with effect from April 8. The exchange has proposed online dissemination of indices namely, Nifty Tata Group 25% Cap, Nifty500 Multicap India Manufacturing 50:30:20, Nifty500 Multicap Infrastructure 50:30:20, and Nifty MidSmall Healthcare, according … Read more

EBITDA growth of 234 cos outpace sales for 3 quarters; over 100 stocks turn multibaggers

EBITDA growth of 234 cos outpace sales for 3 quarters; over 100 stocks turn multibaggers

After seeing testing times in FY23 amid skyrocketing inflation and weak consumer demand, India Inc found solace in FY24 as several companies reported strong double-digit growth in earnings. One of the major factors driving this growth was easing inflationary pressures. As many as 234 companies, excluding banks and financial services, saw operating profit or EBITDA, … Read more

F&O stocks to buy today: RIL, ICICI Bank among top 7 trading ideas for 20 February 2024

F&O stocks to buy today: RIL, ICICI Bank among top 7 trading ideas for 20 February 2024

Indian market is likely to consolidate on Tuesday tracking mixed global cues. The Nifty future closed positive with gains of 0.32% at 22167 levels on Monday. India VIX moved up by 5.22% from 15.22 to 16.02 levels. Volatility slightly rose but created momentum for the bulls. Positive setup was seen in stocks like GMR Infra, … Read more

Big movers on D-Street: What should investors do with Cipla, CDSL and CE Info Systems?

Big movers on D-Street: What should investors do with Cipla, CDSL and CE Info Systems?

Equity indices ended almost flat in highly volatile trade on Thursday. The 30-share BSE Sensex dipped 5 points to settle at 66,017, while Nifty slipped 9 points to end at 19,802. Stocks that were in focus included names like CDSL, which rose 4.71%, Cipla, which fell 7.6%, and CE Info Systems, which rose 1% on … Read more

Hot Stocks: Brokerage view on RIL, Cipla, Maruti Suzuki and Indian Hotels

Hot Stocks: Brokerage view on RIL, Cipla, Maruti Suzuki and Indian Hotels

Brokerage firm Macquarie upgraded RIL to neutral post Q2 results while Jefferies downgraded Cipla to hold. Also, Nomura maintained a neutral rating on Maruti Suzuki and Jefferies had a buy rating on Indian Hotels. We have collated a list of recommendations from top brokerage firms from ETNow and other sources: Macquarie on RIL: Neutral| Target … Read more

Pharma Q2 Preview: Cipla to see steady quarter; higher profit and revenue growth for Dr Reddy’s

Pharma Q2 Preview: Cipla to see steady quarter; higher profit and revenue growth for Dr Reddy’s

Leading pharma players Cipla and Dr Reddy’s will announce their second-quarter results on October 27. Here’s a brief look at what to expect from these companies in the September quarter. CiplaCipla could deliver healthy growth of 5% in the Indian business in the second quarter, but the US business is likely to witness pressure on … Read more

Q2 results, yield movement, FII flows among 7 factors likely to hog Dalal Street this week

Q2 results, yield movement, FII flows among 7 factors likely to hog Dalal Street this week

MUMBAI: Benchmark indices snapped two-week winning streak and net lost over 1% in the week-ended October 20. The rising US bond yields, firm crude oil prices, and weak earnings from IT majors were some of the factors that weighed on the market sentiment. The coming truncated week is likely to bring in volatility as a … Read more